Skip to main content
. 2020 Nov 12;106(2):e824–e835. doi: 10.1210/clinem/dgaa821

Table 3.

Details of patients with partial or absent biochemical or clinical responses

No. PASO Outcomes Imaging Findings Pathology Findings Notes
Bioch. Clin.
1 Complete Partial Negative Hyperplasia 70 yo male seen in follow-up at 136.7 months. Residual hypertension felt to be due to obesity, OSA, and CKD, and was on a beta blocker for heart failure and ventricular tachycardia.
2 Complete Partial Left-sided 0.8-cm nodule Multiple left-sided adenomas with surrounding hyperplasia 55 yo male seen in follow-up at 86.2 months. Residual hypertension felt to be due to obesity.
3 Absent Partial Bilateral bulkiness Right-sided 0.5-cm adenoma 59 yo male with clinical follow-up at 49.3 mo and biochemical follow-up at 46.5 mo. Residual hypertension felt to be due to obesity and bilateral aldosterone-producing adenomas. There was a reduction of the ARR from 3490 pmol/L per ng/mL/hr preoperatively to 2910 pmol/L per ng/mL/hr (ie, PAC 291 pmol/L and PRA 0.1 ng/mL/hr) after surgery. AVS SI was >3 bilaterally postcosyntropin and LI was 38.3.
4 Complete Partial Negative Hyperplasia 52 yo male seen in follow-up at 6.5 mo. Residual hypertension felt to be due to obesity and OSA.
5 Complete Absent Negative Hyperplasia 47 yo male seen in follow-up at 21.2 mo. Residual hypertension felt to be due to obesity and an anxiety disorder, and was on a calcium channel blocker for atrial fibrillation. AVS SI was >2 bilaterally at baseline and >3 bilaterally postcosyntropin and LI was 17.3.
6 Partial Partial Right-sided 0.9-cm nodule Right-sided 1.2-cm adenoma 65 yo male with a history of obesity and OSA, with clinical follow-up at 2.7 mo and biochemical follow-up at 2.3 mo. There was a reduction of the ARR from 447 pmol/L per mIU/L preoperatively to 71 pmol/L per mIU/L (ie, PAC 135 pmol/L and DRC 1.9 mIU/L) after surgery. Lost to further follow-up.
7 Complete Partial Right-sided 0.9-cm nodule Right-sided 1.3-cm adenoma with surrounding hyperplasia 42 yo female with a history of migraine (on metoprolol) and white coat syndrome, seen in follow-up at 1.9 mo. Lost to further follow-up.
8 Complete Absent Left-sided 0.6-cm nodule Left-sided 1.1-cm adenoma 77 yo male seen in follow-up at 2.5 mo. At that time, 24-hr ambulatory blood pressure monitor showed an average BP of 149/80 mm Hg off treatment. He declined further postoperative pharmacological treatment. AVS SI was >3 bilaterally postcosyntropin and LI was 8.4.
9 Complete Partial Left-sided 0.9-cm nodule Left-sided 0.8-cm adenoma with surrounding hyperplasia 67 yo male seen in follow-up at 60.3 mo. Residual hypertension felt to be due to cyclosporine use after kidney transplant, progressive CKD, and obesity.
10 Complete Partial Negative Left-sided 1.5-cm adenoma with surrounding hyperplasia 48 yo male with a history of obesity, OSA, and diuretic use for chronic edema, seen in follow-up at 1.8 mo. Lost to further follow-up.
11 Complete Partial Right-sided 0.7-cm nodule Right-sided 0.7-cm adenoma 49 yo male seen in follow-up at 58.3 mo. Residual hypertension felt to be due to CKD and obesity.
12 Complete Partial Left-sided 0.8-cm nodule Left-sided hyperplasia 45 yo male seen in follow-up at 12.1 mo. Residual hypertension felt to be due to obesity and an anxiety disorder.
13 Complete Partial Negative Right-sided 1.3-cm adenoma 54 yo male seen in follow-up at 23 mo. Residual hypertension felt to be due to obesity.
14 ND Partial Left-sided 0.9-cm nodule Left-sided 1.0-cm adenoma 42 yo female seen in follow-up at 43.9 mo. Residual hypertension felt to be due to essential hypertension, and was on a beta blocker for atrial fibrillation.
15 Complete Partial Negative Right-sided 1.1-cm adenoma 69 yo male seen in follow-up at 57.2 mo. Residual hypertension felt to be due to CKD, and was on a beta blocker for ischemic heart disease.
16 Complete Partial Negative Left-sided 1.0-cm adenoma with surrounding hyperplasia 65 yo male seen in follow-up at 51.6 mo. Residual hypertension felt to be due to obesity.
17 ND Partial Left-sided 0.8-cm nodule Left-sided 1.8-cm adenoma 50 yo male seen in follow-up at 94.9 months. Residual hypertension felt to be due to obesity and daily nonsteroidal anti-inflammatory use for osteoarthritis.
18 Complete Partial Right-sided 0.9-cm nodule Right-sided 1.1-cm adenoma with surrounding hyperplasia 52 yo male with a history of obesity and white coat hypertension seen in follow-up at 0.3 mo. Lost to further follow-up.
19 ND Partial Right-sided nodule <1.0 cm Right-sided 1.7-cm adenoma 62 yo male seen in follow-up at 114.1 mo. Residual hypertension felt to be due to CKD.
20 Complete Partial Left-sided nodule <1.0-cm Left-sided hyperplasia 56 yo male seen in follow-up at 72.1 mo. Residual hypertension felt to be due to obesity, OSA, and was on a calcium channel blocker for atrial fibrillation.
21 Absent Partial Left-sided 0.7-cm nodule Left-sided 0.6-cm adenoma 60 yo male with clinical follow-up at 13.1 mo and biochemical follow-up at 13.1 mo. Residual hypertension felt to be due to bilateral aldosterone-producing adenomas. There was an increase in the ARR from 104 pmol/L per mIU/L preoperatively to 293 pmol/L per mIU/L (ie, PAC 293 pmol/L and DRC 1.0 mIU/L) after surgery. AVS SI was >3 bilaterally postcosyntropin and LI was 3.8.
22 Complete Partial Negative Left-sided 0.9-cm adenoma 40 yo male seen in follow-up at 13.8 mo. Residual hypertension felt to be due to obesity.
23 Complete Absent Left-sided bulkiness Right-sided 0.8-cm adenoma with surrounding hyperplasia 59 yo male seen in follow-up at 28.4 mo. Residual hypertension felt to be due to obesity. AVS SI was >3 bilaterally postcosyntropin and LI was 16.8.
24 Absent Absent Negative Hyperplasia 42 yo male with clinical follow-up at 0.7 mo and biochemical follow-up at 6.8 mo. Residual hypertension felt to be due to bilateral adrenal hyperplasia or unilateral adrenal hyperplasia with concurrent obesity. There was an increase in the ARR from 757 pmol/L per ng/mL/hr (approximately equivalent to 53 pmol/L per ng/mL/hr) preoperatively to 215 pmol/L per mIU/L (ie, PAC 862 pmol/L and DRC 4.0 mIU/L) after surgery. Lost to further follow-up. AVS SI was >2 bilaterally at baseline and >3 bilaterally postcosyntropin and LI was 20.9.
25 Absent Absent Right-sided 0.9-cm nodule and left-sided bulkiness Left-sided hyperplasia 52 yo male seen in clinical follow-up at 1.2 mo and biochemical follow-up at 0.8 mo. Residual hypertension felt to be due to bilateral adrenal hyperplasia. There was a reduction of the ARR from 4589 pmol/L per ng/mL/hr preoperatively to 4194 pmol/L per ng/mL/hr (ie, PAC 1057 pmol/L and PRA 0.25 ng/mL/hr) after surgery. Lost to further follow-up. AVS SI was >3 bilaterally postcosyntropin and LI was 23.2.
26 Partial Partial Left-sided 0.8-cm nodule with surrounding bulkiness Left-sided 0.9-cm adenoma 45 yo male seen in clinical follow-up at 0.7 mo and biochemical follow-up at 11.9 mo. Residual hypertension felt to be due to obesity. There was a reduction of the ARR from 10680 pmol/L per ng/mL/hr preoperatively to 690 pmol/L per ng/mL/hr (ie, PAC 283 pmol/L and PRA 0.41 ng/mL/hr) after surgery. Lost to further follow-up.
27 Complete Partial Negative Left-sided 0.9-cm adenoma 50 yo male seen in follow-up at 6.3 mo. Unknown cause of residual hypertension.
28 Absent Partial Left-sided bulkiness Right-sided 0.5-cm adenoma with surrounding hyperplasia 54 yo male seen in clinical follow-up at 22.2 mo and biochemical follow-up at 9.0 mo. Residual hypertension felt to be due to obesity, OSA, and CKD, and was on a diuretic for chronic edema. There was a reduction of the ARR from 422 pmol/L per mIU/L preoperatively to 134 pmol/L per mIU/L (ie, PAC 470 pmol/L and DRC 3.5 mIU/L) after surgery. AVS SI was >2 bilaterally at baseline and >3 bilaterally postcosyntropin, and LI was 3.3.
29 Complete Partial Left-sided bulkiness Hyperplasia 54 yo male with a history of obesity and type 2 diabetes mellitus seen in follow-up at 0.2 mo. Lost to further follow-up.

Abbreviations: AVS, adrenal vein sampling; Bioch., Biochemical; BP, blood pressure; CKD, chronic kidney disease; Clin., Clinical; DRC, direct renin concentration; hr, hours; LI, lateralization index; mo, months; ND, no data; SI, selectivity index; OSA, obstructive sleep apnea; PAC, plasma aldosterone concentration; PRA, plasma renin activity; yo, year-old.